Related references
Note: Only part of the references are listed.Cannabis use and patterns of psychotic symptomatology in a longitudinal birth cohort
Nicole Cant et al.
NEW ZEALAND MEDICAL JOURNAL (2022)
Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients
Monica Rais et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
Celia J. A. Morgan et al.
BRITISH JOURNAL OF PSYCHIATRY (2008)
Schizophrenia, Just the facts: What we know in 2008: Part I: overview
Rajiv Tandon et al.
SCHIZOPHRENIA RESEARCH (2008)
Contradictory cognitive capacities among substance-abusing patients with schizophrenia: A meta-analysis
Stephane Potvin et al.
SCHIZOPHRENIA RESEARCH (2008)
Cannabis use and brain structural alterations in first episode schizophrenia - A region of interest, voxel based morphometric study
Srihari S. Bangalore et al.
SCHIZOPHRENIA RESEARCH (2008)
Genotype effects of CHRNA7, CNRI and COMT in schizophrenia:: interactions with tobacco and cannabis use
Stanley Zammit et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
Elevated plasma dopamine metabolites in cannabis psychosis
Malcolm B. Bowers et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients:: Impact of cannabis use
F. Markus Leweke et al.
SCHIZOPHRENIA RESEARCH (2007)
Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression
D. Koethe et al.
JOURNAL OF NEURAL TRANSMISSION (2007)
Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia
Philip R. Szeszko et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia
Kelly A. Newell et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Cerebral grey, white matter and csf in never-medicated, first-episode schizophrenia
Siew E. Chua et al.
SCHIZOPHRENIA RESEARCH (2007)
Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders
Luis San et al.
EUROPEAN ADDICTION RESEARCH (2007)
Substance misuse and cognitive functioning in early psychosis: A 2 year follow-up
Amanda McCleery et al.
SCHIZOPHRENIA RESEARCH (2006)
Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness
Dagmar Koethe et al.
SCHIZOPHRENIA RESEARCH (2006)
An experimental study of catechol-O-methyltransferase Val158Met moderation of Δ-9-tetrahydrocannabinol-induced effects on psychosis and cognition
Cecile Henquet et al.
NEUROPSYCHOPHARMACOLOGY (2006)
The acute effects of cannabinoids on memory in humans: a review
Mohini Ranganathan et al.
PSYCHOPHARMACOLOGY (2006)
Feasibility of central cannabinoid CB1 receptor imaging with [124I] AM281 PET demonstrated in a schizophrenic patient
Georg Berding et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2006)
(AAT)n repeat in the cannabinoid receptor gene, CNR1:: association with schizophrenia in a Spanish population
Isabel Martinez-Gras et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2006)
Brain volume changes in the first year of illness and 5-year outcome of schizophrenia
W. Cahn et al.
BRITISH JOURNAL OF PSYCHIATRY (2006)
Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders
Mary F. Brunette et al.
SCHIZOPHRENIA BULLETIN (2006)
Cannabidiol monotherapy for treatment-resistant schizophrenia
Antonio Waldo Zuardi et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2006)
Effects of the cannabinoid CB1 receptor agonist CP55,940 and antagonist SR141716A on d-amphetamine-induced behaviours in Cebus monkeys
Morten V. Madsen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2006)
Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia
Kelly A. Newell et al.
EXPERIMENTAL BRAIN RESEARCH (2006)
Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: Therapeutic implications
ET Tzavara et al.
BIOLOGICAL PSYCHIATRY (2006)
Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases
M Arendt et al.
BRITISH JOURNAL OF PSYCHIATRY (2005)
What causes the onset of psychosis?
MR Broome et al.
SCHIZOPHRENIA RESEARCH (2005)
Ionotropic glutamate receptor binding in the posterior cingulate cortex in schizophrenia patients
KA Newell et al.
NEUROREPORT (2005)
Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up
J Stirling et al.
SCHIZOPHRENIA RESEARCH (2005)
Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction
A Caspi et al.
BIOLOGICAL PSYCHIATRY (2005)
Clozapine decreases [3H] CP 55940 binding to the cannabinoid1 receptor in the rat nucleus accumbens
S Sundram et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2005)
Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction
DC D'Souza et al.
BIOLOGICAL PSYCHIATRY (2005)
Tests of causal linkages between cannabis use and psychotic symptoms
DM Fergusson et al.
ADDICTION (2005)
Altered brain tissue composition in heavy marijuana users
JA Matochik et al.
DRUG AND ALCOHOL DEPENDENCE (2005)
Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods
MP Viveros et al.
BEHAVIOURAL PHARMACOLOGY (2005)
Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people
C Henquet et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Cannabis and brain morphology in recent-onset schizophrenia
W Cahn et al.
SCHIZOPHRENIA RESEARCH (2004)
Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia
K Zavitsanou et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2004)
Cannabis use and age at onset of schizophrenia
ND Veen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis
DC D'Souza et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and Schizoaffective disorder
HY Meltzer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms
A Giuffrida et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Reduced binocular depth inversion in regular cannabis users
DM Semple et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2003)
Genome scan meta-analysis of schizophrenia and bipolar disorder, part II:: Schizophrenia
CM Lewis et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Cannabis-sensitive dopaminergic markers in postmortem central nervous system: Changes in schizophrenia
B Dean et al.
BIOLOGICAL PSYCHIATRY (2003)
Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice:: evidence for a CB3 receptor
E Fride et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects
R Mechoulam et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2002)
Clinical characteristics of adolescents later hospitalized for schizophrenia
M Weiser et al.
AMERICAN JOURNAL OF MEDICAL GENETICS (2002)
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study
L Arseneault et al.
BRITISH MEDICAL JOURNAL (2002)
Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study
S Zammit et al.
BRITISH MEDICAL JOURNAL (2002)
Cannabis use and psychosis: A longitudinal population-based study
J van Os et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia
H Ujike et al.
MOLECULAR PSYCHIATRY (2002)
Reduced binocular depth inversion in schizophrenic patients
U Schneider et al.
SCHIZOPHRENIA RESEARCH (2002)
Schizophrenia and the cannabinoid receptor type 1 (CB1):: Association study using a single-base polymorphism in coding exon 1
S Leroy et al.
AMERICAN JOURNAL OF MEDICAL GENETICS (2001)
Cannabis induced dopamine release: an in-vivo SPECT study
LNP Voruganti et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2001)
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
T Bisogno et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Studies on [H-3]CP-55940 binding in the human central nervous system: Regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use
B Dean et al.
NEUROSCIENCE (2001)
Different effects of nabilone and cannabidiol on binocular depth inversion in man
FM Leweke et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2000)
Effects of frequent marijuana use on brain tissue volume and composition
RI Block et al.
NEUROREPORT (2000)
Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia
SJ Tsai et al.
PSYCHIATRIC GENETICS (2000)
Share Paper
